back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-03-21 Tx date 2017-03-17 |
$GCI
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 9206-8618 Quebec Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,250
+10,000 vol $0.72 each |
460,000 | |
| Filed 2017-03-09 Tx date 2013-05-28 |
$GCI
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-15,000
-37,500 vol $0.40 each |
1,037,500 | |
| Filed 2017-03-09 Tx date 2017-03-01 |
$GCI
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 9206-8618 Quebec Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,600
-20,000 vol $0.78 each |
470,000 | |
| Filed 2017-03-09 Tx date 2015-10-03 |
$GCI
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-20,000
-100,000 vol $0.20 each |
1,000,000 | |
| Filed 2017-03-02 Tx date 2017-02-28 |
$GCI
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 9206-8618 Quebec Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,000
-20,000 vol $0.85 each |
490,000 | |
| Filed 2017-03-02 Tx date 2017-03-02 |
$GCI
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 9206-8618 Quebec Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,600
-20,000 vol $0.78 each |
470,000 | |
| Filed 2017-02-28 Tx date 2017-02-24 |
$GCI
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-75,000
-1,500,000 vol $0.05 each |
37,500 | |
| Filed 2017-02-28 Tx date 2017-02-24 |
$GCI
Tetra Bio-Pharma Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$75,000
+1,500,000 vol $0.05 each |
6,699,284 | |
| Filed 2017-02-24 Tx date 2017-02-23 |
$GCI
Tetra Bio-Pharma Inc. |
Chotard, Benoit
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
550,000 | |
| Filed 2017-02-24 Tx date 2017-02-23 |
$GCI
Tetra Bio-Pharma Inc. |
Di Paola, Sabino Roberto
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$105,000
+150,000 vol $0.70 each |
150,000 | |
| Filed 2017-02-24 Tx date 2017-02-23 |
$GCI
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 9206-8618 Quebec Inc (Indirect Ownership)
|
Options
50 - Grant of options
|
$105,000
+150,000 vol $0.70 each |
1,400,000 | |
| Filed 2017-02-24 Tx date 2016-04-01 |
$GCI
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-02-24 Tx date 2017-02-23 |
$GCI
Tetra Bio-Pharma Inc. |
Chamberland, Guy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$105,000
+150,000 vol $0.70 each |
150,000 | |
| Filed 2017-02-23 Tx date 2017-02-23 |
$GCI
Tetra Bio-Pharma Inc. |
Brouillette, Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$105,000
+150,000 vol $0.70 each |
550,000 | |
| Filed 2017-02-17 Tx date 2017-02-07 |
$GCI
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 9206-8618 Quebec Inc (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-3,500
-70,000 vol $0.05 each |
680,000 | |
| Filed 2017-02-17 Tx date 2017-02-15 |
$GCI
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-24,000
-480,000 vol $0.05 each |
||
| Filed 2017-02-17 Tx date 2017-02-14 |
$GCI
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 9206-8618 Quebec Inc (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-10,000
-200,000 vol $0.05 each |
480,000 | |
| Filed 2017-02-17 Tx date 2017-02-07 |
$GCI
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-3,500
-70,000 vol $0.05 each |
||
| Filed 2017-02-17 Tx date 2016-09-19 |
$GCI
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-02-17 Tx date 2017-02-14 |
$GCI
Tetra Bio-Pharma Inc. |
Rancourt, André
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-10,000
-200,000 vol $0.05 each |